Development and economic assessment of machine learning models to predict glycosylated hemoglobin in type 2 diabetes
Background: Glycosylated hemoglobin (HbA1c) is recommended for diagnosing and monitoring type 2 diabetes. However, the monitoring frequency in real-world applications has not yet reached the recommended frequency in the guidelines. Developing machine learning models to screen patients with poor glyc...
Saved in:
Published in | Frontiers in pharmacology Vol. 14; p. 1216182 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
30.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!